title: Intensified glucose lowering in type 2 diabetes: time for a bolder reappraisal.
authors.forename: L
authors.initials: L
authors.lastname: Czupryniak
authors.forename: E
authors.initials: E
authors.lastname: Szymańska-Garbacz
authors.forename: M
authors.initials: M
authors.lastname: Pawłowski
authors.forename: M
authors.initials: M
authors.lastname: Saryusz-Wolska
authors.forename: J
authors.initials: J
authors.lastname: Loba
mesh_terms: D001786:Blood Glucose / Q000187:drug effects*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D006943:Hyperglycemia / Q000097:blood / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents